|
Anticoagulants
Citations 201-210 of 258 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Inhibition of Factor Xa Reduces Ischemic Brain Damage After Thromboembolic Stroke in Rats
- Xinkang Wang, Lin Xu, Hugh Wang, Reinhard Grzanna, Yutian Zhan, Robert M. Knabb, Joseph M. Luettgen, Tracy A. Bozarth, Robert A. Galemmo, Pancras C. Wong, Roberta Bernard, Hugo Vargas, Michael Chopp, Steven M. Friedman, and Giora Z. Feuerstein
Stroke published January 16, 2003, doi:10.1161/01.STR.0000049765.81774.A3
[Abstract]
- Original Contributions
Delayed Argatroban Treatment Reduces Edema in a Rat Model of Intracerebral Hemorrhage
- Takuji Kitaoka, Ya Hua, Guohua Xi, Julian T. Hoff, and Richard F. Keep
Stroke 2002;33:3012-3018; published online before print as doi:10.1161/01.STR.0000037673.17260.1B
[Abstract]
[Full text]
- Original Contributions
Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients
- Phillip A. Scott, Arthur M. Pancioli, Lisa A. Davis, Shirley M. Frederiksen, and John Eckman
Stroke 2002;33:2664-2669, doi:10.1161/01.STR.0000035260.70403.88
[Abstract]
[Full text]
- Comments, Opinions, and Reviews
Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy: Analysis of Randomized Clinical Trials
- Robert G. Hart, Santiago Palacio, and Lesly A. Pearce
Stroke 2002;33:2722-2727, doi:10.1161/01.STR.0000035735.49388.4A
[Abstract]
[Full text]
- Articles
Delayed Argatroban Treatment Reduces Edema in a Rat Model of Intracerebral Hemorrhage
- Takuji Kitaoka, Ya Hua, Guohua Xi, Julian T. Hoff, and Richard F. Keep
Stroke published October 17, 2002, doi:10.1161/01.STR.0000037673.17260.1B
[Abstract]
- Cochrane Corner
Low-Molecular-Weight Heparins or Heparinoids Versus Standard Unfractionated Heparin for Acute Ischemic Stroke (Cochrane Review)
- Carl Counsell and Peter Sandercock
Stroke 2002;33:1925-1926, doi:10.1161/01.STR.0000018820.99077.46
[Full text]
- Emerging Therapies
Considering the Role of Heparin and Low-Molecular-Weight Heparins in Acute Ischemic Stroke
- Majaz Moonis and Marc Fisher
Stroke 2002;33:1927-1933, doi:10.1161/01.STR.0000019422.63054.5F
[Abstract]
[Full text]
- Original Contributions
Use of Intravenous Heparin by North American Neurologists: Do the Data Matter?
- Ahmad Al-Sadat, Mohammad Sunbulli, and Seemant Chaturvedi
Stroke 2002;33:1574-1577, doi:10.1161/01.STR.0000018081.33541.E3
[Abstract]
[Full text]
- Emerging Therapies
Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial: Is Warfarin Really a Reasonable Therapeutic Alternative to Aspirin for Preventing Recurrent Noncardioembolic Ischemic Stroke?
- Graeme J. Hankey
Stroke 2002;33:1723-1726, doi:10.1161/01.STR.0000016922.22707.27
[Full text]
- Original Contributions
Validation of a Weight-Based Nomogram for the Use of Intravenous Heparin in Transient Ischemic Attack or Stroke
- Cory Toth and Chris Voll
Stroke 2002;33:670-674, doi:10.1161/hs0302.104168
[Abstract]
[Full text]
|
|
